Treatment OutcomeAntineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantCombined Modality TherapyAntineoplastic AgentsTumor Markers, BiologicalCisplatinDoxorubicinCell Line, TumorCyclophosphamideTumor BurdenTumor Necrosis Factor-alphaNeoplasm StagingBreast NeoplasmsDisease-Free SurvivalNeoadjuvant TherapySurvival AnalysisBrain NeoplasmsSurvival RateWilms TumorNeoplasm MetastasisNeoplasmsEtoposidePrognosisAdenocarcinomaLung NeoplasmsNeoplasm Recurrence, LocalNeoplasms, ExperimentalTumor Suppressor Protein p53Drug Administration ScheduleOvarian NeoplasmsGenes, Tumor SuppressorCarcinoid TumorPaclitaxelMethotrexateCarboplatinTime FactorsLiver NeoplasmsNeuroendocrine TumorsTumor Suppressor ProteinsVinblastineTesticular NeoplasmsTumor MicroenvironmentBone NeoplasmsInduction ChemotherapyFollow-Up StudiesAntimetabolites, AntineoplasticNeovascularization, PathologicXenograft Model Antitumor AssaysCarcinoma, Squamous CellCarcinoma, Non-Small-Cell LungIfosfamideColonic NeoplasmsMammary Neoplasms, ExperimentalDeoxycytidineAntineoplastic Agents, AlkylatingBleomycinDisease ProgressionTaxoidsOrganoplatinum CompoundsNeoplasms, Germ Cell and EmbryonalAntibodies, MonoclonalCell ProliferationTransplantation, HeterologousLymphatic MetastasisPancreatic NeoplasmsDrug Resistance, NeoplasmDose-Response Relationship, DrugOsteosarcomaNeoplasm ProteinsChemotherapy, Cancer, Regional PerfusionGliomaStomach NeoplasmsAntibiotics, AntineoplasticMice, Inbred BALB CAntigens, NeoplasmAnthracyclinesKaplan-Meier EstimateSalvage TherapyLymphomaRadiotherapyImmunohistochemistryRadiotherapy, AdjuvantCytarabineLymphoma, Non-HodgkinGastrointestinal Stromal TumorsMice, NudeKidney NeoplasmsSarcomaProspective StudiesTomography, X-Ray ComputedCell DivisionRNA, MessengerSkin NeoplasmsDacarbazinePeritoneal NeoplasmsHodgkin DiseaseDNA, NeoplasmTransplantation, AutologousHead and Neck Neoplasms